LC–MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid–liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients-Reference-Cited by-同舟云学术

LC–MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid–liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients

Published:2017-10 Issue: Volume:145 Page:33-39
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Iwamoto Noriko,Shimomura Akihiko,Tamura Kenji,Hamada Akinobu,Shimada Takashi

Funder

National Cancer Center Research and Development Fund

Practical Research for Innovative Cancer Control Funds

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference28 articles.

1. Maturing antibody-drug conjugate pipeline hits 30;Mullard;Nat. Rev. Drug Discov.,2013

2. Potential of antibody-drug conjugates and novel therapeutics in breast cancer management;Lianos;OncoTargets and therapy,2014

3. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules;Mitsunaga;Nat. Med.,2011

4. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity;Ogitani;Cancer Sci.,2016

5. Arming antibodies: prospects and challenges for immunoconjugates;Wu;Nat. Biotechnol.,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying payloads of antibody‒drug conjugates using a postcolumn infused-internal standard strategy with LC‒MS;Analytica Chimica Acta;2024-05

2. A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics;2022-04-23

3. A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics;The Analyst;2022

4. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry;Journal of Chromatography A;2021-10

5. Ansamitocin P3-Loaded Gold-NanoCage Conjugated with Immune Checkpoint Inhibitor to Enhance Photo-Chemo-Thermal Maturation of Dendritic Cells for Hepatocellular Carcinoma;Polymers;2021-08-15